Abbott Labs (ABT) PT Lowered to $121 at Goldman Sachs
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $108.79 -1.52%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Goldman Sachs analyst David Roman lowered the price target on Abbott Labs (NYSE: ABT) to $121.00 (from $140.00) while maintaining a Conviction Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Neste Oyj (NESTE:FH) (NTOIY) to Buy
- HelleniQ Energy (ELPE:GA) PT Raised to EUR17.80 at Goldman Sachs
- VersaBank (VBNK) PT Lowered to $20 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
